🟢 HCW Biologics is trading 9.4% up

HCW Biologics is trading at $1.28, up 9.36%, with the precise catalyst unclear.

• No HCW Biologics-specific announcement for October 15 was confirmed.
• Its latest company release, on October 9, discussed FDA guidance and preparation of an IND application planned for the first half of 2027.
• Biotech’s XBI sector was up 2.20%, a possible tailwind that does not establish the cause of the larger share move.